Evaluation of Clinicopathologic Factors and Surgery Management on Borderline Ovarian Tumor Outcomes
Background: Borderline ovarian tumor (BOT) is a tumor most prevalent in young woman with desire to fertility. There are some controversies on the patient characteristic besides to the factors affecting the recurrence rate among different races. Objectives: The aim of this study is to evaluate clinic...
Saved in:
Published in | International Journal of Cancer Management Vol. 15; no. 10 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
01.10.2022
|
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Borderline ovarian tumor (BOT) is a tumor most prevalent in young woman with desire to fertility. There are some controversies on the patient characteristic besides to the factors affecting the recurrence rate among different races. Objectives: The aim of this study is to evaluate clinicopathologic features of the tumor to discover the controversies on the topic. Methods: Medical data of the all referred patients to Motahari clinic from January 2010 till October 2020 were recorded. Patient clinicopathologic characteristics affecting on outcome were evaluated. By using SPSS software, data were tested by chi-square and fish exact test. Also, log rank test was used for survival analysis Results: Totally 145 patients were enrolled. 61.4% versus 38.6% of the patients underwent fertility sparing surgery and radical surgery respectively with common characteristics of mostly belong to stage 1A disease (61.8% vs. 66.1%), unilateral (93.3% vs. 89.3%), serous histology (51.7% vs. 66.1%). The characteristics were different in the aspects of age and tumor size. In the aspect of recurrence rate, higher FIGO stage, younger age, tumor size less than 10cm, performing laparoscopy and fertility sparing surgery were with higher rate of recurrence (P-value < 0.05) while histology type of the tumor, lateralization, micropapillary, microinvasion, noninvasive peritoneal implants, receiving adjuvant chemotherapy and performing lymphadenectomy were not statistically significant for recurrence (P-value > 0.05). Two patients had malignant transformation. Conclusions: Fertility sparing surgery was with more recurrence rate in borderline ovarian tumor patients. However, micropapillary, microinvasion were not significantly with higher recurrence rate in our study but they are challenging issues in border line ovarian tumors among different studies. Due to most prevalence of border line ovarian tumors in young women and desire of fertility preservation, we should notice more to clinicopathologic and surgery types affecting on recurrence of BOTs. |
---|---|
AbstractList | Background: Borderline ovarian tumor (BOT) is a tumor most prevalent in young woman with desire to fertility. There are some controversies on the patient characteristic besides to the factors affecting the recurrence rate among different races. Objectives: The aim of this study is to evaluate clinicopathologic features of the tumor to discover the controversies on the topic. Methods: Medical data of the all referred patients to Motahari clinic from January 2010 till October 2020 were recorded. Patient clinicopathologic characteristics affecting on outcome were evaluated. By using SPSS software, data were tested by chi-square and fish exact test. Also, log rank test was used for survival analysis Results: Totally 145 patients were enrolled. 61.4% versus 38.6% of the patients underwent fertility sparing surgery and radical surgery respectively with common characteristics of mostly belong to stage 1A disease (61.8% vs. 66.1%), unilateral (93.3% vs. 89.3%), serous histology (51.7% vs. 66.1%). The characteristics were different in the aspects of age and tumor size. In the aspect of recurrence rate, higher FIGO stage, younger age, tumor size less than 10cm, performing laparoscopy and fertility sparing surgery were with higher rate of recurrence (P-value < 0.05) while histology type of the tumor, lateralization, micropapillary, microinvasion, noninvasive peritoneal implants, receiving adjuvant chemotherapy and performing lymphadenectomy were not statistically significant for recurrence (P-value > 0.05). Two patients had malignant transformation. Conclusions: Fertility sparing surgery was with more recurrence rate in borderline ovarian tumor patients. However, micropapillary, microinvasion were not significantly with higher recurrence rate in our study but they are challenging issues in border line ovarian tumors among different studies. Due to most prevalence of border line ovarian tumors in young women and desire of fertility preservation, we should notice more to clinicopathologic and surgery types affecting on recurrence of BOTs. |
Author | Hashemi, Masooumeh Hajisafari Tafti, Mojgan Namazi, Niloofar Najib, Fateme Sadat Shiravani, Zahra |
Author_xml | – sequence: 1 givenname: Zahra orcidid: 0000-0001-5796-2954 surname: Shiravani fullname: Shiravani, Zahra – sequence: 2 givenname: Niloofar orcidid: 0000-0002-9993-6209 surname: Namazi fullname: Namazi, Niloofar – sequence: 3 givenname: Masooumeh orcidid: 0000-0002-3298-5612 surname: Hashemi fullname: Hashemi, Masooumeh – sequence: 4 givenname: Fateme Sadat orcidid: 0000-0003-3396-145X surname: Najib fullname: Najib, Fateme Sadat – sequence: 5 givenname: Mojgan orcidid: 0000-0001-7352-9341 surname: Hajisafari Tafti fullname: Hajisafari Tafti, Mojgan |
BookMark | eNo1kMtOAjEARRuDiYis_IHuzWiftF0qATTBsBATd5NOH1gz05J2hoS_F4Ku7t2cszi3YBRTdADcY_TIJSZP4cd0FcZMYXQFxoRTWTElvkb_nxFyA6alhAZRhJjgiI-BWRx0O-g-pAiTh_M2xGDSXvffqU27YOBSmz7lAnW08GPIO5eP8F1HvXOdiz08YS8pW5dPoIObg85BR7gdupThZuhN6ly5A9det8VN_3YCPpeL7fy1Wm9Wb_PndWUIkX3lvMZKKMIEsVrMqGKeC-tmTjXeUdlY1hDJnSSWUD4T0iJPufJU0kYwrymdgIeL1-RUSna-3ufQ6XysMarPiepzovqSiP4C4yBdcg |
Cites_doi | 10.1016/j.ygyno.2020.02.007 10.1016/j.bpobgyn.2011.12.006 10.1186/s12885-020-07262-w 10.1016/j.fertnstert.2020.07.043 10.20471/acc.2019.58.01.04 10.1093/humrep/dez307 10.1016/j.ejso.2019.11.001 10.1111/IGC.0b013e3181a84699 10.1186/s12885-018-4932-2 10.1007/s00404-014-3364-8 10.1016/j.jmig.2020.08.018 10.1016/s1470-2045(11)70288-1 10.1200/jco.2001.19.10.2658 10.2147/cmar.s250394 10.1111/1471-0528.13840 10.1016/j.ygyno.2011.08.008 10.1093/annonc/mdu139 10.1016/j.dib.2020.105653 10.1016/j.ygyno.2010.11.016 10.1111/jog.14210 10.1080/01443615.2018.1499076 10.1080/00016340801995640 10.1111/aogs.14013 10.1007/s00404-017-4496-4 10.1007/s00404-020-05716-x 10.1111/1471-0528.14598 10.3332/ecancer.2020.1031 10.3892/ol.2014.2758 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.5812/ijcm-114910 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2538-497X |
ExternalDocumentID | 10_5812_ijcm_114910 |
GroupedDBID | AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION M~E |
ID | FETCH-LOGICAL-c228t-efa19792472da76394f57de6e9bfe38bd4b285e82d235678d0f359f383b74fa33 |
ISSN | 2538-4422 |
IngestDate | Fri Aug 23 01:57:32 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c228t-efa19792472da76394f57de6e9bfe38bd4b285e82d235678d0f359f383b74fa33 |
ORCID | 0000-0002-3298-5612 0000-0002-9993-6209 0000-0001-7352-9341 0000-0003-3396-145X 0000-0001-5796-2954 |
OpenAccessLink | https://brieflands.com/articles/ijcm-114910.pdf |
ParticipantIDs | crossref_primary_10_5812_ijcm_114910 |
PublicationCentury | 2000 |
PublicationDate | 2022-10-01 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | International Journal of Cancer Management |
PublicationYear | 2022 |
References | key-A114910REF27-27 key-A114910REF25-25 key-A114910REF1-1 key-A114910REF2-2 key-A114910REF3-3 key-A114910REF4-4 key-A114910REF12-12 key-A114910REF10-10 key-A114910REF18-18 key-A114910REF14-14 key-A114910REF16-16 key-A114910REF23-23 key-A114910REF21-21 key-A114910REF26-26 key-A114910REF28-28 key-A114910REF24-24 key-A114910REF13-13 key-A114910REF5-5 key-A114910REF11-11 key-A114910REF17-17 key-A114910REF6-6 key-A114910REF15-15 key-A114910REF7-7 key-A114910REF19-19 key-A114910REF8-8 key-A114910REF9-9 key-A114910REF22-22 key-A114910REF20-20 |
References_xml | – ident: key-A114910REF2-2 doi: 10.1016/j.ygyno.2020.02.007 – ident: key-A114910REF4-4 doi: 10.1016/j.bpobgyn.2011.12.006 – ident: key-A114910REF24-24 doi: 10.1186/s12885-020-07262-w – ident: key-A114910REF25-25 doi: 10.1016/j.fertnstert.2020.07.043 – ident: key-A114910REF14-14 doi: 10.20471/acc.2019.58.01.04 – ident: key-A114910REF5-5 doi: 10.1093/humrep/dez307 – ident: key-A114910REF7-7 doi: 10.1016/j.ejso.2019.11.001 – ident: key-A114910REF27-27 doi: 10.1111/IGC.0b013e3181a84699 – ident: key-A114910REF19-19 doi: 10.1186/s12885-018-4932-2 – ident: key-A114910REF20-20 doi: 10.1007/s00404-014-3364-8 – ident: key-A114910REF26-26 doi: 10.1016/j.jmig.2020.08.018 – ident: key-A114910REF23-23 doi: 10.1016/s1470-2045(11)70288-1 – ident: key-A114910REF28-28 doi: 10.1200/jco.2001.19.10.2658 – ident: key-A114910REF1-1 doi: 10.2147/cmar.s250394 – ident: key-A114910REF10-10 doi: 10.1111/1471-0528.13840 – ident: key-A114910REF8-8 doi: 10.1016/j.ygyno.2011.08.008 – ident: key-A114910REF22-22 doi: 10.1093/annonc/mdu139 – ident: key-A114910REF17-17 doi: 10.1016/j.dib.2020.105653 – ident: key-A114910REF12-12 doi: 10.1016/j.ygyno.2010.11.016 – ident: key-A114910REF6-6 doi: 10.1111/jog.14210 – ident: key-A114910REF11-11 doi: 10.1080/01443615.2018.1499076 – ident: key-A114910REF9-9 doi: 10.1080/00016340801995640 – ident: key-A114910REF18-18 doi: 10.1111/aogs.14013 – ident: key-A114910REF13-13 doi: 10.1007/s00404-017-4496-4 – ident: key-A114910REF15-15 doi: 10.1007/s00404-020-05716-x – ident: key-A114910REF16-16 doi: 10.1111/1471-0528.14598 – ident: key-A114910REF3-3 doi: 10.3332/ecancer.2020.1031 – ident: key-A114910REF21-21 doi: 10.3892/ol.2014.2758 |
SSID | ssib030047505 ssib044740538 |
Score | 2.251586 |
Snippet | Background: Borderline ovarian tumor (BOT) is a tumor most prevalent in young woman with desire to fertility. There are some controversies on the patient... |
SourceID | crossref |
SourceType | Aggregation Database |
Title | Evaluation of Clinicopathologic Factors and Surgery Management on Borderline Ovarian Tumor Outcomes |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEF6l9NJLRQVVH1DtgVvkEPaR9R4LSoSQIIckUsQlWtu7IlETV8bhwIGfwG_u7CO2U3IALlZkeS0n82Xmm_U3MwidQIzvMa16kTS2JEcI8IOC0ijjsUi6OpWxGzZxfdO7nLCrKZ-2Ws8N1dK6TDrp4866kvdYFc6BXW2V7BssW90UTsBnsC8cwcJwfJWN-1WrbqeqcEWOuZ0x7D1aexCG6Th5pq9_buhd7HuCc9d601HN4QOkzfBvH6-XedEerkt44iAwXNRy9-3dw0BlLyx0ih1SmtHdvFAPfmxU-1bdFVUQuFFL9Tj3WPyT50YVtS-8t00MfCHRfZ6D86y3rNVi7l4gDYAiL3V7pDJVNjcuIOfdSOCCfyPW1zLmy5I7unFOiumWg-ZNIHZ3OX4OPAWsNV-kEFgg6QtS2a322v-FvUqMCGmQXT6zi2d-8Qf0kQjJrUT0-qm_8U-2ORkQrMr_MSaA7rph6dV38SWg9n6njYdpkJ4Gexnvo8_BVvi3x9AX1NKrA5TW-MG5wS_wgwN-MOAHB_zg2sgYltX4wQE_2OEHb_BziCaD_vjiMgpDN6KUkLiMtFFnUkBWLkimIPhIZrjIdE_LxGgaJxlLSMx1TDJCOTCdrGsol4bGNBHMKEq_or1VvtLfELbtAOE6TiTwxEydxcqkjCob1xiHtOE7Otn8KrO_vrfKbIcxfrzusp_oU42yI7RXFmt9DISxTH45K_4DBjpvJA |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | ISSN International Centre |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+Clinicopathologic+Factors+and+Surgery+Management+on+Borderline+Ovarian+Tumor+Outcomes&rft.jtitle=International+Journal+of+Cancer+Management&rft.au=Shiravani%2C+Zahra&rft.au=Namazi%2C+Niloofar&rft.au=Hashemi%2C+Masooumeh&rft.au=Najib%2C+Fateme+Sadat&rft.date=2022-10-01&rft.issn=2538-4422&rft.eissn=2538-497X&rft.volume=15&rft.issue=10&rft_id=info:doi/10.5812%2Fijcm-114910&rft.externalDBID=n%2Fa&rft.externalDocID=10_5812_ijcm_114910 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2538-4422&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2538-4422&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2538-4422&client=summon |